Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1αJiali Zhao, Jian Li|Drug Design Development and Therapy|2022Cited by 16
Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent PathwayJunlu Tong, Jian Li|Diabetes Metabolic Syndrome and Obesity|2022Cited by 12
Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary CirrhosisZhigan Jiang, Shuhui Chen, Zhiliang Yuan et al.|ACS Medicinal Chemistry Letters|2019Cited by 7